Shire (pharmaceutical company)
http://dbpedia.org/resource/Shire_(pharmaceutical_company) an entity of type: Thing
Shire PLC war ein 1986 gegründetes Pharmaunternehmen mit rechtlichem Sitz in Saint Helier auf Jersey und operativen Sitzen im irischen Dublin sowie im britischen Hampshire. Anfang Januar 2019 gab Shire bekannt, dass die Akquisition von Shire durch das japanische Pharmaunternehmen Takeda vollzogen ist.
rdf:langString
Shire, anciennement Shire Pharmaceuticals Group, est une entreprise pharmaceutique britannique.
rdf:langString
シャイアー（英: Shire plc）は、武田薬品工業の子会社の一つであり、希少疾患に関する医薬品の開発・製造を行う、製薬およびバイオテクノロジー企業。本社はアイルランド・ダブリンに置かれている（登記上の本店はチャンネル諸島のセント・ヘリア）。
rdf:langString
Shire plc was a UK-founded Jersey-registered specialty biopharmaceutical company. Originating in the United Kingdom with an operational base in the United States, its brands and products included Vyvanse, Lialda, and Adderall XR. Shire was acquired by Takeda Pharmaceutical Company on 8 January 2019.
rdf:langString
rdf:langString
Shire PLC
rdf:langString
Shire (entreprise)
rdf:langString
シャイアー (企業)
rdf:langString
Shire (pharmaceutical company)
rdf:langString
Shire plc
rdf:langString
Shire plc
xsd:integer
936402
xsd:integer
871579
xsd:integer
1122563544
xsd:integer
1
rdf:langString
Acquired by Takeda
rdf:langString
Flemming Ornskov
rdf:langString
Thomas Dittrich
rdf:langString
Shire logo.svg
rdf:langString
$4,271.5 million
xsd:integer
23044
rdf:langString
$2,455.2 million
rdf:langString
Shire Pharmaceuticals Group Plc
rdf:langString
$15,160.6 million
rdf:langString
Shire Plc Acquisitions
rdf:langString
NASDAQ:SHPG
rdf:langString
center
rdf:langString
Shire PLC war ein 1986 gegründetes Pharmaunternehmen mit rechtlichem Sitz in Saint Helier auf Jersey und operativen Sitzen im irischen Dublin sowie im britischen Hampshire. Anfang Januar 2019 gab Shire bekannt, dass die Akquisition von Shire durch das japanische Pharmaunternehmen Takeda vollzogen ist.
rdf:langString
Shire, anciennement Shire Pharmaceuticals Group, est une entreprise pharmaceutique britannique.
rdf:langString
Shire plc was a UK-founded Jersey-registered specialty biopharmaceutical company. Originating in the United Kingdom with an operational base in the United States, its brands and products included Vyvanse, Lialda, and Adderall XR. Shire was acquired by Takeda Pharmaceutical Company on 8 January 2019. Shire was a global biotechnology company focused on serving people with rare diseases and other highly specialized conditions. The company's products were available in more than 100 countries across core therapeutic areas including Hematology, Immunology, Neuroscience, Lysosomal Storage Disorders, Gastrointestinal / Internal Medicine / Endocrine and Hereditary Angioedema; a growing franchise in Oncology; and an emerging, innovative pipeline in Ophthalmics. The original corporate headquarters was located in Basingstoke, Hampshire, England. Main offices are located in Dublin, Ireland, the United States in Cambridge, Massachusetts, and Chicago, Illinois, and in Zug, Switzerland. In addition, Shire owns manufacturing sites in Lexington, Massachusetts, and Social Circle, Georgia. Shire's headquarters in Lexington, Massachusetts, will be integrated with Takeda's new U.S. headquarters, which is being relocated from Deerfield, Illinois, to the Boston area.
rdf:langString
シャイアー（英: Shire plc）は、武田薬品工業の子会社の一つであり、希少疾患に関する医薬品の開発・製造を行う、製薬およびバイオテクノロジー企業。本社はアイルランド・ダブリンに置かれている（登記上の本店はチャンネル諸島のセント・ヘリア）。
rdf:langString
JE00B2QKY057
xsd:nonNegativeInteger
42121
rdf:langString
Acquired byTakeda
xsd:gYear
1986
<usDollar>
4271.0
xsd:nonNegativeInteger
23044
<usDollar>
2455.0
<usDollar>
15160.0
